AI Analysis · Q1 2026 · Q1 2026
Based on the SEC 13F filing data provided for Enavate Sciences GP, LLC as of September 30, 2025, here is a comprehensive analysis of the portfolio.
1. Portfolio Overview
Enavate Sciences GP, LLC manages a highly concentrated, high-conviction portfolio with a total value of $224.23 million. The fund exhibits a distinct lack of diversification, holding only five securities, with the top three positions accounting for over 82% of the total assets. The portfolio experienced significant growth d...
Quarter at a glance — Q1 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q1 2026.
Filing history
Filing history loading…